Recent Updates — DROR

Dror Ortho-Design entered into a Securities Purchase Agreement for a private placement of $245,000 in zero-coupon debentures maturing December 31, 2026. The transaction includes warrants contingent on a future public offering. Additionally, holders of $2,400,000 in prior debentures issued between June and August 2026 elected to extend the maturity date to December 31, 2026. No other terms were modified for the prior debt. The company operates in the orthopedic medical device industry.

On August 19, 2026, Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement to sell $275,000 in aggregate principal amount of debentures due October 19, 2026, via private placement. The zero-interest-bearing debentures automatically convert into common stock upon the consummation of a future public offering at the offering's per-share price. Additionally, the company issued warrants to purchase shares equal to 150% of the resulting conversion shares or 100% of public offering warrants, depending on timing. This transaction represents a significant new financing event for the entity.